Identification of oligodendrocytes in experimental disease models

GLIA

Volumn 50, Issue 4, 2005, Pages 321-328

  Ness, Jennifer K ^a   Valentino, Mario ^a   McIver, Sally R ^a   Goldberg, Mark P ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Campus Box 8111 ^*  (United States)

Author keywords

Gene transfer; Histology; Immunocytochemical identification; New methods; Oligodendrocytes

Indexed keywords

BIOCHEMICAL MARKER;

ANIMAL MODEL; CELL CULTURE; CELL DAMAGE; CELL NUCLEUS; CELL SELECTION; CELL STRUCTURE; CELL SURVIVAL; CELL TYPE; EXPERIMENTAL MODEL; GENE TRANSFER; GRAY MATTER; HISTOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REVIEW; TISSUE FIXATION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; WHITE MATTER;

ANIMALS; DISEASE MODELS, ANIMAL; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; OLIGODENDROGLIA;

EID: 20344369090     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20206     Document Type: Review

References (53)

1. Baekelandt V, Claeys A, Eggermont K, Lauwers E, De Strooper B, Nuttin B, Debyser Z. 2002. Characterization of lentiviral vector-mediated gene transfer in adult mouse brain. Hum Gene Ther 13:841-853.
2. Belachew S, Yuan X, Gallo V. 2001. Unraveling oligodendrocyte origin and function by cell-specific transgenesis. Dev Neurosci 23:287-298.
3. Benediktsson AM, Schachtele SJ, Green SH, Dailey ME. 2004. Ballistic labeling and dynamic imaging of astrocytes in organotypic hippocampal slice cultures. J Neurosci Methods 141:41-53.
4. Bhat RV, Axt KA, Fosnaugh JS, Smith KJ, Johnson KA, Hill DE, Kinzler KW, Baraban JM. 1996. Expression of the APC tumor suppressor protein in oligodendroglia. Glia 17:169-174.
5. Blomer U, Naldini L, Kafri T, Trono D, Verma IM, Gage FH. 1997. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 71:6641-6649.
6. Brakeman JSF, Gu SH, Wang XB, Dolin G, Baraban JM. 1999. Neuronal localization of the adenomatous polyposis coli tumor suppressor protein. Neuroscience 91:661-672.
7. Brierley JB, Prior PF, Calverley J, Brown AW. 1977. Cyanide intoxication in Macaca mulatta. Physiological and neuropathological aspects. J Neurol Sci 31:133-157.
8. Butt AM. 2005. Structure and function of oligodendrocytes. In: Kettenmann H, Ransom BR, editors. Neuroglia. New York: Oxford University Press. p 36-47.
9. Butt AM, Ransom BR. 1989. Visualization of oligodendrocytes and astrocytes in the intact rat optic nerve by intracellular injection of Lucifer yellow and horseradish peroxidase. Glia 2:470-475.
10. Caplan LR, Schoene WC. 1978. Clinical features of subcortical arteriosclerotic encephalopathy (Binswanger disease). Neurology 28:1206-1215.
11. Chandross KJ, Cohen RI, Paras P Jr, Gravel M, Braun PE, Hudson LD. 1999. Identification and characterization of early glial progenitors using a transgenic selection strategy. J Neurosci 19:759-774.
12. Chandross KJ, Champagne B, Auble K, Hudson LD. 2001. Tracking oligodendrocytes during development and regeneration. Microscopy Res Tech 52:766-777
13. Chen H, McCarty DM, Bruce AT, Suzuki K, Suzuki K. 1998. Gene transfer and expression in oligodendrocytes under the control of myelin basic protein transcriptional control region mediated by adeno-associated virus. Gene Ther 5:50-58.
14. Chen H, McCarty DM, Bruce AT, Suzuki K, Suzuki K. 1999. Oligodendrocyte-specific gene expression in mouse brain: use of a myelin-forming cell type-specific promoter in an adeno-associated virus. J Neurosci Res 55:504-513.
15. Dewar D, Dawson D. 1995. Tau protein is altered by focal cerebral ischaemia in the rat: an immunohistochemical and immunoblotting study. Brain Res 684:70-78.
16. Dubois-Dalcq M, Behar T, Hudson L, Lazzarini RA. 1986. Emergence of three myelin proteins in oligodendrocytes cultured without neurons. J Cell Biol 102:384-392.
17. Franklin R, Quick M, Haase G. 1999. Adenoviral vectors for in vivo gene delivery to oligodendrocytes: transgene expression and cytopathic consequences. Gene Ther 6:1360-1367.
18. Friedman B, Hockfield S, Black JA, Woodruff KA, Waxman SG. 1989. In situ demonstration of mature oligodendrocytes and their processes: an immunocytochemical study with a new monoclonal antibody, RIP. Glia 2:380-390.
19. Fuss B, Mallon B, Phan T, Ohlemeyer C, Kirchhoff F, Nishiyama A, Macklin WB. 2000. Purification and analysis of in vivo-differentiated oligodendrocytes expressing the green fluorescent protein. Dev Biol 218:259-274.
20. Fuss B, Braun C, Raivich G, Kirchhoff F. 2002. Imaging analysis of oligodendrocytes during myelination and trauma in living brain tissue of PLP-DSRED mice. Glia Suppl 1:S67.
21. Garcia JH, Kalimo H, Kamijyo Y, Trump BF. 1977. Cellular events during partial cerebral ischemia. I. Electron microscopy of feline cerebral cortex after middle-cerebral-artery occlusion. Virchows Arch B Cell Pathol 25:191-206.
22. Gow A, Friedrich VL Jr, Lazzarini RA. 2002. Myelin basic protein gene contains separate enhancers for oligodendrocyte and Schwann cell expression. J Cell Biol 119:605-616.
23. Gravel M, Di Polo A, Valera PB, Braun PE. 1998. Four-kilobase sequence of the mouse CNP gene directs spatial and temporal expression of lacZ in transgenic mice. J Neurosci Res 53:393-404.
24. Gu C, Casaccia-Bonnefil P, Srinivasan A, Chao MV. 1999. Oligodendrocyte apoptosis mediated by caspase activation. J Neurosci 19:3043-3049.
25. Guo Z, Yang NS, Jiao S, Sun J, Cheng L, Wolff JA, Duncan ID. 1996. Efficient and sustained transgene expression in mature rat oligodendrocytes in primary culture. J Neurosci Res 43:32-41.
26. Hollensworth SB, Shen C, Sim JE, Spitz DR, Wilson GL, LeDoux SP. 2000. Glial cell type-specific responses to menadione-induced oxidative stress. Free Radic Biol Med 28:1161-1174.
27. Kettenmann H, Ransom BR. 2005. The concept of neuroglia: a historical perspective. In: Kettenmann H, Ransom BR, editors. Neuroglia. New York: Oxford University Press. p 1-16.
28. Krueger WH, Madison DL, Pfeiffer SE. 1998. Transient transfection of oligodendrocyte progenitors by electroporation. Neurochem Res 23:421-426.
29. Linington C, Webb M, Woodhams PL. 1984. A novel myelin associated glycoprotein defined by a mouse monoclonal antibody. J of Neuroimmunol 6:387-396.
30. Macauley SL, Ness JK, Lee C, Snider BJ, Green SH, Sands MS, Goldberg MP. 2004. Lentiviral vector expression of GFP in cultured oligodendrocytes. Program 467.21. Abstract. Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2004. Online.
31. Mallon BS, Shick HE, Kidd GJ, Macklin WB. 2002. Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J Neurosci 22:876-885.
32. Masumura M, Hata R, Uetsuki T, Nishimura I, Nagai Y, Sawada T. 2001. In vivo gene transfer to cerebral white matter lesions with a recombinant adenovirus vector. Biochem Biophys Res Commun 287:440-444.
33. Matysiak M, Jurewicz A, Jaskolski D, Selmaj K. 2002. TRAIL induces death of human oligodendrocyte isolated from adult brain. Brain 125:2469-2480.
34. McBride CB, McPhail LT, Vanderluit JL, Tetzlaff W, Steeves JD. 2003. Caspase inhibition attenuates transaction-induced oligodendrocyte apoptosis in the developing chick spinal cord. Mol Cell Neurosci 23:383-397.
35. McIver SR, Lee C, Snider BJ, Green SH, Sands MS, Goldberg MP. 2004. In vivo GFP expression in oligodendrocytes using lentiviral vectors. Program No. 467.22. 2004 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2004. Online.
36. Naldini L, Blomer U, Gage FH, Trono D, Verma IM. 1996. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 93:11382-11388.
37. Ness JK, Goldberg MP. 2005. Oligodendrocyte and Schwann cell injury. In: Kettenmann H, Ransom BR, editors. Neuroglia. New York: Oxford University Press. p 430-442.
38. + oligodendrocyte progenitors. Glia 46:183-194.
39. Peters A, Palay SL, Webster HdeF. 1991. The fine structure of the nervous system: neurons and their supporting cells. New York, NY: Oxford University Press. p 295-302.
40. Pantoni L, Garcia JH. 1995. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke 26:1293-1301.
41. Pantoni L, Garcia JH, Gutierrez JA. 1996. Cerebral white matter is highly vulnerable to ischemia. Stroke 27:1641-1646.
42. Sanchez-Gomez MV, Alberdi E, Ibarretxe G, Torre I, Matute C. 2003. Caspase-dependent and caspase-independent oligodendrocyte death mediated by AMPA and kainate receptors. J Neurosci 23:9519-9528.
43. Sarlieve LL, Delaundy JP, Dierich A, Ebel A, Fabre M, Mandel P, Rebel G, Vincendon G, Wintzerith M, Yusufi AN. 1981. Investigations on myelination in vitro III. Ultrastructural: brain cells from embryonic mice. J Neurosci Res 6:659-683.
44. Shibata M, Hisahara S, Hara H, Yamawaki T, Fukuuchi Y, Yuan J, Okano H, Miura M. 2000. Caspases determine the vulnerability of oligodendrocytes in the ischemic brain. J Clin Invest 106:643-653.
45. Shibata M, Hattori H, Sasaki T, Gotoh J, Hamada J, Fukuuchi Y. 2002. Temporal profiles of the subcellular locatization of Bim, a BH3-only protein, during middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 22:810-820.
46. Sprinkle TJ, Sheedlo HJ, Buxton TB, Rissing JP. 1983. Immunochemical identification of 2′, 3′-cyclic nucleotide 3′- phosphodiesterase in central and peripheral nervous system myelin, the Wolfgram protein fraction, and bovine oligodendrocytes. J Neurochem 41:1664-1671.
47. Stankoff B, Demerens C, Goujet-Zalc C, Monge M, Peyron F, Mikoshiba K, Zalc B, Lubetzki C. 1996. Transcription of myelin basic protein promoted by regulatory elements in the proximal 5′ sequence requires myelinogenesis. Mult Scler 2:125-132.
48. Valentino M, Inoue I, Macklin WB, Kirchhoff F, Goldberg MP. 2004. White matter hypoglycemic injury revealed by multiphoton microscopy in transgenic mice. Program No. 1018.6. 2004 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2004. Online.
49. Valeriani V, Dewar D, McCulloch J. 2000. Quantitative assessment of ischemic pathology in axons, oligodendrocytes, and neurons: attenuation of damage after transient ischemia. J Cereb Blood Flow Metab 20:765-771.
50. Volpe JJ. 2001. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 50:553-562.
51. Watson DJ, Koginer GP, Passini MA, Wilson JM, Wolfe JH. 2002. Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins. Mol Ther 5:528-537.
52. Wight PA, Duchala CS, Readhead C, Macklin WB. 1993. A myelin proteolipid protein-LacZ fusion protein is developmentally regulated and targeted to the myelin membrane in transgenic mice. J Cell Biol 123:443-454.
53. Yuan X, Chittajallu R, Belachew S, Anderson S, McBain CJ, Gallo V. 2002. Expression of the Green Fluorescent Protein in the oligodendrocyte lineage: a transgenic mouse for developmental and physiological studies. J Neurosci Res 70:529-545.